La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.

Identifieur interne : 000162 ( PubMed/Checkpoint ); précédent : 000161; suivant : 000163

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.

Auteurs : Yehezkel Ben-Ari [France] ; Philippe Damier [France] ; Eric Lemonnier [France]

Source :

RBID : pubmed:27147965

Abstract

The diuretic bumetanide failed to treat acute seizures due to hypoxic ischemic encephalopathy (HIE) in newborn babies and was associated with hearing loss (NEMO trial, Pressler et al., 2015). On the other hand, clinical and experimental observations suggest that the diuretic might provide novel therapy for many brain disorders including Autism Spectrum Disorders (ASD), schizophrenia, Rett syndrome, and Parkinson disease. Here, we discuss the differences between the pathophysiology of severe recurrent seizures in the neonates and neurological and psychiatric disorders stressing the uniqueness of severe seizures in newborn in comparison to other disorders.

DOI: 10.3389/fncel.2016.00090
PubMed: 27147965


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:27147965

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.</title>
<author>
<name sortKey="Ben Ari, Yehezkel" sort="Ben Ari, Yehezkel" uniqKey="Ben Ari Y" first="Yehezkel" last="Ben-Ari">Yehezkel Ben-Ari</name>
<affiliation wicri:level="1">
<nlm:affiliation>INMED - Institut National de la Santé et de la Recherche Médicale U901, Aix-Marseille University Marseilles, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INMED - Institut National de la Santé et de la Recherche Médicale U901, Aix-Marseille University Marseilles</wicri:regionArea>
<wicri:noRegion>Aix-Marseille University Marseilles</wicri:noRegion>
<wicri:noRegion>Aix-Marseille University Marseilles</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Damier, Philippe" sort="Damier, Philippe" uniqKey="Damier P" first="Philippe" last="Damier">Philippe Damier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 0004 Nantes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 0004 Nantes</wicri:regionArea>
<wicri:noRegion>Centre d'Investigation Clinique 0004 Nantes</wicri:noRegion>
<wicri:noRegion>Centre d'Investigation Clinique 0004 Nantes</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lemonnier, Eric" sort="Lemonnier, Eric" uniqKey="Lemonnier E" first="Eric" last="Lemonnier">Eric Lemonnier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hôpital Le Cluzeau, CHU Limoges Limoges, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Le Cluzeau, CHU Limoges Limoges</wicri:regionArea>
<wicri:noRegion>CHU Limoges Limoges</wicri:noRegion>
<wicri:noRegion>CHU Limoges Limoges</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27147965</idno>
<idno type="pmid">27147965</idno>
<idno type="doi">10.3389/fncel.2016.00090</idno>
<idno type="wicri:Area/PubMed/Corpus">000155</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000155</idno>
<idno type="wicri:Area/PubMed/Curation">000155</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000155</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000155</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000155</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.</title>
<author>
<name sortKey="Ben Ari, Yehezkel" sort="Ben Ari, Yehezkel" uniqKey="Ben Ari Y" first="Yehezkel" last="Ben-Ari">Yehezkel Ben-Ari</name>
<affiliation wicri:level="1">
<nlm:affiliation>INMED - Institut National de la Santé et de la Recherche Médicale U901, Aix-Marseille University Marseilles, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INMED - Institut National de la Santé et de la Recherche Médicale U901, Aix-Marseille University Marseilles</wicri:regionArea>
<wicri:noRegion>Aix-Marseille University Marseilles</wicri:noRegion>
<wicri:noRegion>Aix-Marseille University Marseilles</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Damier, Philippe" sort="Damier, Philippe" uniqKey="Damier P" first="Philippe" last="Damier">Philippe Damier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 0004 Nantes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 0004 Nantes</wicri:regionArea>
<wicri:noRegion>Centre d'Investigation Clinique 0004 Nantes</wicri:noRegion>
<wicri:noRegion>Centre d'Investigation Clinique 0004 Nantes</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lemonnier, Eric" sort="Lemonnier, Eric" uniqKey="Lemonnier E" first="Eric" last="Lemonnier">Eric Lemonnier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hôpital Le Cluzeau, CHU Limoges Limoges, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Le Cluzeau, CHU Limoges Limoges</wicri:regionArea>
<wicri:noRegion>CHU Limoges Limoges</wicri:noRegion>
<wicri:noRegion>CHU Limoges Limoges</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Frontiers in cellular neuroscience</title>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The diuretic bumetanide failed to treat acute seizures due to hypoxic ischemic encephalopathy (HIE) in newborn babies and was associated with hearing loss (NEMO trial, Pressler et al., 2015). On the other hand, clinical and experimental observations suggest that the diuretic might provide novel therapy for many brain disorders including Autism Spectrum Disorders (ASD), schizophrenia, Rett syndrome, and Parkinson disease. Here, we discuss the differences between the pathophysiology of severe recurrent seizures in the neonates and neurological and psychiatric disorders stressing the uniqueness of severe seizures in newborn in comparison to other disorders.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">27147965</PMID>
<DateCreated>
<Year>2016</Year>
<Month>05</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2016</Year>
<Month>05</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>05</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>10</Volume>
<PubDate>
<Year>2016</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in cellular neuroscience</Title>
<ISOAbbreviation>Front Cell Neurosci</ISOAbbreviation>
</Journal>
<ArticleTitle>Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.</ArticleTitle>
<Pagination>
<MedlinePgn>90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fncel.2016.00090</ELocationID>
<Abstract>
<AbstractText>The diuretic bumetanide failed to treat acute seizures due to hypoxic ischemic encephalopathy (HIE) in newborn babies and was associated with hearing loss (NEMO trial, Pressler et al., 2015). On the other hand, clinical and experimental observations suggest that the diuretic might provide novel therapy for many brain disorders including Autism Spectrum Disorders (ASD), schizophrenia, Rett syndrome, and Parkinson disease. Here, we discuss the differences between the pathophysiology of severe recurrent seizures in the neonates and neurological and psychiatric disorders stressing the uniqueness of severe seizures in newborn in comparison to other disorders.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ben-Ari</LastName>
<ForeName>Yehezkel</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>INMED - Institut National de la Santé et de la Recherche Médicale U901, Aix-Marseille University Marseilles, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Damier</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 0004 Nantes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lemonnier</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Hôpital Le Cluzeau, CHU Limoges Limoges, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>04</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Front Cell Neurosci</MedlineTA>
<NlmUniqueID>101477935</NlmUniqueID>
<ISSNLinking>1662-5102</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4830840</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">GABA</Keyword>
<Keyword MajorTopicYN="N">autism</Keyword>
<Keyword MajorTopicYN="N">bumetanide</Keyword>
<Keyword MajorTopicYN="N">clinical trials</Keyword>
<Keyword MajorTopicYN="N">epilepsy</Keyword>
<Keyword MajorTopicYN="N">parkinson disease</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>02</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>03</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>5</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>5</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>5</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27147965</ArticleId>
<ArticleId IdType="doi">10.3389/fncel.2016.00090</ArticleId>
<ArticleId IdType="pmc">PMC4830840</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Ben Ari, Yehezkel" sort="Ben Ari, Yehezkel" uniqKey="Ben Ari Y" first="Yehezkel" last="Ben-Ari">Yehezkel Ben-Ari</name>
</noRegion>
<name sortKey="Damier, Philippe" sort="Damier, Philippe" uniqKey="Damier P" first="Philippe" last="Damier">Philippe Damier</name>
<name sortKey="Lemonnier, Eric" sort="Lemonnier, Eric" uniqKey="Lemonnier E" first="Eric" last="Lemonnier">Eric Lemonnier</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000162 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000162 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:27147965
   |texte=   Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:27147965" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024